Roche to Acquire Up to 56% Interest in Foundation Medicine
Companies in the healthcare sector often collaborate for development and commercialization of products or to bring together their expertise, technical knowhow and resources. Oncology major Roche ( RHHBY ) recently announced that it has entered into a strategic collaboration agreement to acquire up to a 56.3% stake in Foundation Medicine, Inc. ( FMI ), a molecular information and genomic analysis company, on a fully diluted basis through a tender and acquisition of newly issued shares […]